Publications by authors named "Christopher Oermann"

Claim this Profile
E
Evaluating the Impact of CFTR Modulator Therapy on Antibiotic Utilization: Insights From a Single Center Retrospective Review and Pediatric Health Information System Database.
Stephanie R Duehlmeyer, Ann L Wirtz, Alaina Burns, Christopher M Oermann, Brian R Lee

J Pediatric Infect Dis Soc· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful treatment of Stenotrophomonas maltophilia with ceftazidime-avibactam and aztreonam in an individual with cystic fibrosis: A case report.
Stephanie Duehlmeyer, Ellen Meier, Christopher Oermann

Pediatr Pulmonol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adapting to change: A description of prescribing practices of asthma controller medications at a pediatric institution.
Jade Tam-Williams, Christopher Oermann, Stephanie Duehlmeyer

Pediatr Pulmonol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Elexacaftor/Tezacaftor/Ivacaftor on Acquisition and Chronic Infection at a Single Pediatric Cystic Fibrosis Care Center.
Stephanie Duehlmeyer, Elizabeth Claire Elson, Christopher M Oermann

J Pediatr Pharmacol Ther· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Child Health and the Pediatric Pulmonology Workforce: 2020-2040.
Terry L Noah, Debra Boyer, Stephanie D Davis, Robert J Vinci, Christopher M Oermann

Pediatrics· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Tic Disorder in a Child With Cystic Fibrosis Treated With Elexacaftor/Tezacaftor/Ivacaftor.
Stephanie R Duehlmeyer, E Claire Elson, Christopher M Oermann

J Pediatr Pharmacol Ther· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in fecal elastase-1 following initiation of CFTR modulator therapy in pediatric patients with cystic fibrosis.
Kimberly G Stephenson, Abby J Lingle, Kelly A Baumberger, Elisabeth P Dellon, Charles R Esther, Christopher M Oermann

J Cyst Fibros· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time to man up: Increased risk of testicular cancer among boys with cystic fibrosis.
Christopher M Oermann

J Pediatr Urol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The history of workforce concerns in pediatric pulmonary Medicine.
Christopher M Oermann, Thomas Lahiri, Stacey L Peterson-Carmichael, Pnina Weiss

Pediatr Pulmonol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A statement on the current status and future needs of the pediatric pulmonology workforce: Pipeline Workgroup.
Benjamin A Nelson, Debra Boyer, Thomas Lahiri, Christopher M Oermann, Jennifer A Rama

Pediatr Pulmonol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An assessment of fellowship training issues affecting the pediatric pulmonary medicine workforce.
Charles R Esther, Christopher M Oermann, Kristie R Ross, Pnina Weiss

Pediatr Pulmonol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic answers for children: Dynamic analyses of >1000 pediatric rare disease genomes.
Ana S A Cohen, Emily G Farrow, Ahmed T Abdelmoity, Joseph T Alaimo, Shivarajan M Amudhavalli, Christopher M Oermann

Genet Med· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The implementation of an aminoglycoside induced ototoxicity algorithm for people with cystic fibrosis.
E Claire Elson, Ellen Meier, Christopher M Oermann

J Cyst Fibros· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 16-year-old with Lemierre's syndrome and multiple septic pulmonary emboli.
Christopher M Oermann

Pediatr Pulmonol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Innovating and adapting in pediatric pulmonology and sleep medicine during the COVID-19 pandemic: ATS pediatric assembly web committee consensus statement for initial COVID-19 virtual response.
Jane B Taylor, Christopher M Oermann, Robin R Deterding, Gregory Redding, Stephanie D Davis

Pediatr Pulmonol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of telemedicine to provide clinical pharmacy services during the SARS-CoV-2 pandemic.
E Claire Elson, Christopher Oermann, Stephanie Duehlmeyer, Sarah Bledsoe

Am J Health Syst Pharm· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endobronchial Glomus Tumor in a Child.
Moshe Y Prero, Melissa Gener, Eugenio M Taboada, Christopher M Oermann

Pediatr Allergy Immunol Pulmonol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aztreonam Lysine Inhalation Solution in Cystic Fibrosis.
Elizabeth Claire Elson, Joel Mermis, Deepika Polineni, Christopher M Oermann

Clin Med Insights Circ Respir Pulm Med· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cystic Fibrosis Foundation Pulmonary Guidelines. Use of Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy in Patients with Cystic Fibrosis.
Clement L Ren, Rebecca L Morgan, Christopher Oermann, Helaine E Resnick, Cynthia Brady

Ann Am Thorac Soc· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ATS Core Curriculum 2016: Part III. Pediatric Pulmonary Medicine.
Debra Boyer, Carey C Thomson, Robyn Cohen, Devika Rao, Sharon Dell, Christopher M Oermann

Ann Am Thorac Soc· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enterovirus d68. A focused review and clinical highlights from the 2014 U.S. Outbreak.
Christopher M Oermann, Jennifer E Schuster, Gregory P Conners, Jason G Newland, Rangaraj Selvarangan

Ann Am Thorac Soc· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cystic Fibrosis Foundation pulmonary guideline. pharmacologic approaches to prevention and eradication of initial Pseudomonas aeruginosa infection.
Peter J Mogayzel, Edward T Naureckas, Karen A Robinson, Cynthia Brady, Margaret Guill, Christopher M Oermann

Ann Am Thorac Soc· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhaled aztreonam lysine vs. inhaled tobramycin in cystic fibrosis: a comparative efficacy trial.
Baroukh M Assael, Tacjana Pressler, Diana Bilton, Michael Fayon, Rainald Fischer, Christopher M Oermann

J Cyst Fibros· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pseudomonas aeruginosa antibiotic susceptibility during long-term use of aztreonam for inhalation solution (AZLI).
Christopher M Oermann, Karen S McCoy, George Z Retsch-Bogart, Ronald L Gibson, Matthew McKevitt

J Antimicrob Chemother· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An 18-month study of the safety and efficacy of repeated courses of inhaled aztreonam lysine in cystic fibrosis.
Christopher M Oermann, George Z Retsch-Bogart, Alexandra L Quittner, Ronald L Gibson, Karen S McCoy

Pediatr Pulmonol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis